The role of vascular endothelial growth factor in peritoneal hyperpermeability during CAPD-related peritonitis

Perit Dial Int. 2002 Mar-Apr;22(2):265-7.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Count
  • Dialysis Solutions / chemistry
  • Endothelial Growth Factors / analysis
  • Endothelial Growth Factors / physiology*
  • Humans
  • Lymphokines / analysis
  • Lymphokines / physiology*
  • Peritoneal Dialysis, Continuous Ambulatory / adverse effects*
  • Peritoneum / pathology
  • Peritoneum / physiopathology*
  • Peritonitis / etiology
  • Peritonitis / physiopathology*
  • Permeability
  • Pilot Projects
  • Transforming Growth Factor beta / analysis
  • Transforming Growth Factor beta1
  • Tumor Necrosis Factor-alpha / analysis
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors

Substances

  • Dialysis Solutions
  • Endothelial Growth Factors
  • Lymphokines
  • TGFB1 protein, human
  • Transforming Growth Factor beta
  • Transforming Growth Factor beta1
  • Tumor Necrosis Factor-alpha
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors